ANIP NASDAQ
ANI Pharmaceuticals, Inc.
1W: +4.0%
1M: +3.3%
3M: +6.4%
YTD: +5.5%
1Y: +36.5%
3Y: +86.9%
5Y: +136.1%
$82.72
-0.05 (-0.06%)
Weekly Expected Move ±4.2%
$71
$75
$78
$81
$85
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026322
Institutions Holding
+3 vs prior
85.0%
Ownership
-2.86%
39
New
101
Increased
144
Reduced
78
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Walsh Patrick D | director | S-Sale | 10,000 | $80.63 | $806K | Filing |
| 2026-05-13 | Cook Meredith | officer: sr. vp, general counsel & sec. | S-Sale | 500 | $78.16 | $39K | Filing |
| 2026-05-11 | Walsh Patrick D | director | S-Sale | 3,973 | $80.75 | $321K | Filing |
| 2026-03-13 | Cook Meredith | officer: sr. vp, general counsel & sec. | S-Sale | 500 | $72.62 | $36K | Filing |
| 2026-03-13 | Mutz Christopher | officer: head of rare disease | S-Sale | 3,162 | $71.64 | $227K | Filing |
| 2026-03-11 | Rowland Thomas Andrew | officer: svp, head - established brands | S-Sale | 4,772 | $74.91 | $357K | Filing |
| 2026-03-05 | CAREY STEPHEN P. | officer: svp & cfo | S-Sale | 4,000 | $75.56 | $302K | Filing |
| 2026-03-05 | CAREY STEPHEN P. | officer: svp & cfo | S-Sale | 3,312 | $75.42 | $250K | Filing |
| 2026-03-03 | Gutwerg Ori | officer: svp, generics | S-Sale | 2,060 | $76.50 | $158K | Filing |
| 2026-03-03 | Walsh Patrick D | director | S-Sale | 6,000 | $74.23 | $445K | Filing |
| 2026-03-02 | Mutz Christopher | officer: head of rare disease | S-Sale | 417 | $74.00 | $31K | Filing |
| 2026-02-28 | Cook Meredith | officer: sr. vp, general counsel & sec. | F-Tax Withholding | 1,555 | $73.90 | $115K | Filing |
| 2026-02-28 | Davis Krista | officer: svp, chief hr officer | F-Tax Withholding | 1,555 | $73.90 | $115K | Filing |
| 2026-02-28 | Gassert Chad | officer: svp - corp. dev. & strategy | F-Tax Withholding | 2,221 | $73.90 | $164K | Filing |
| 2026-02-28 | Mutz Christopher | officer: head of rare disease | F-Tax Withholding | 2,221 | $73.90 | $164K | Filing |
| 2026-02-28 | Gutwerg Ori | officer: svp, generics | F-Tax Withholding | 2,221 | $73.90 | $164K | Filing |
| 2026-02-28 | Lalwani Nikhil | officer: president & ceo | F-Tax Withholding | 12,217 | $73.90 | $903K | Filing |
| 2026-02-28 | CAREY STEPHEN P. | officer: svp & cfo | F-Tax Withholding | 2,773 | $73.90 | $205K | Filing |
| 2026-02-28 | Rowland Thomas Andrew | officer: svp, head - established brands | F-Tax Withholding | 628 | $73.90 | $46K | Filing |
| 2026-02-26 | Cook Meredith | officer: sr. vp, general counsel & sec. | A-Grant/Award | 13,895 | $77.15 | $1.1M | Filing |
| 2026-02-26 | Shanmugam Muthusamy | officer: head of r&d, coo-novitium ops | A-Grant/Award | 11,116 | $77.15 | $858K | Filing |
| 2026-02-26 | Mutz Christopher | officer: head of rare disease | A-Grant/Award | 21,306 | $77.15 | $1.6M | Filing |
| 2026-02-26 | Gutwerg Ori | officer: svp, generics | A-Grant/Award | 12,969 | $77.15 | $1.0M | Filing |
| 2026-02-26 | CAREY STEPHEN P. | officer: svp & cfo | A-Grant/Award | 22,233 | $77.15 | $1.7M | Filing |
| 2026-02-26 | Rowland Thomas Andrew | officer: svp, head - established brands | A-Grant/Award | 6,021 | $77.15 | $465K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,747,492 | $211M | +85,780 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 823,064 | $63M | +823,064 | 2026-03-31 | Filing |
| Soleus Capital Management, L.P. | 820,243 | $63M | +334,000 | 2026-03-31 | Filing |
| STATE STREET CORP | 771,587 | $59M | +44,383 | 2026-03-31 | Filing |
| TANG CAPITAL MANAGEMENT LLC | 707,500 | $54M | +226,063 | 2026-03-31 | Filing |
| GOLDENTREE ASSET MANAGEMENT LP | 667,981 | $51M | +667,981 | 2026-03-31 | Filing |
| Deep Track Capital, LP | 600,000 | $46M | +122,316 | 2026-03-31 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 564,360 | $43M | +91,153 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 531,190 | $41M | +43,523 | 2026-03-31 | Filing |
| UBS Group AG | 497,702 | $38M | +346,923 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 489,201 | $38M | +11,929 | 2026-03-31 | Filing |
| Nuveen, LLC | 402,357 | $31M | +15,255 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 375,965 | $29M | +375,965 | 2026-03-31 | Filing |
| Ranger Investment Management, L.P. | 360,083 | $28M | -2,295 | 2026-03-31 | Filing |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 327,276 | $25M | +10,583 | 2026-03-31 | Filing |
| Invesco Ltd. | 324,349 | $25M | +134,513 | 2026-03-31 | Filing |
| DEUTSCHE BANK AG | 319,675 | $25M | -72,901 | 2026-03-31 | Filing |
| Jones Hill Capital LP | 318,591 | $24M | +318,591 | 2026-03-31 | Filing |
| KENNEDY CAPITAL MANAGEMENT LLC | 293,996 | $23M | +80,195 | 2026-03-31 | Filing |
| NOMURA ASSET MANAGEMENT INTERNATIONAL IN | 287,563 | $22M | -11,715 | 2026-03-31 | Filing |